Market Cap

Revance Therapeutics, Inc. Market Capitalization:

$733.2 Million

USD as of Jan. 1, 2024

business Revance Therapeutics, Inc. Company Profile

Revance Therapeutics, Inc. Main Stock Listing

NASDAQ: RVNC

Market Capitalization History of Revance Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Revance Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $733.2 M -68.37%
Jan. 1, 2023 $2.32 B 102.32%
Jan. 1, 2022 $1.15 B -47.60%
Jan. 1, 2021 $2.19 B 13.72%
Jan. 1, 2020 $1.92 B 29.53%
Jan. 1, 2019 $1.48 B -46.53%
Jan. 1, 2018 $2.78 B 61.50%
Jan. 1, 2017 $1.72 B -3.52%
Jan. 1, 2016 $1.78 B 28.76%
Jan. 1, 2015 $1.38 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Revance Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Revance Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: RVNC

Stock: FSX: RTI

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.